49th week of 2018 patent applcation highlights part 10 |
Patent application number | Title | Published |
20180344686 | MICROENCAPSULATED CANNABINOID COMPOSITIONS | 2018-12-06 |
20180344687 | COMPOSITIONS AND METHODS TO REGULATE HORMONAL CASCADES IN STRESS DISORDERS | 2018-12-06 |
20180344688 | Dosage Delivery Film | 2018-12-06 |
20180344689 | COMPLEX OF A GLUCOPYRANOSYL DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | 2018-12-06 |
20180344690 | Methods and Formulation for Enhancing Response to Radiotherapy | 2018-12-06 |
20180344691 | Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth | 2018-12-06 |
20180344692 | METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS | 2018-12-06 |
20180344693 | STABILIZED STATIN FORMULATIONS | 2018-12-06 |
20180344694 | USE OF INDOLE COMPOUNDS TO STIMULATE THE IMMUNE SYSTEM | 2018-12-06 |
20180344695 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS | 2018-12-06 |
20180344696 | SYNERGISTIC COMBINATION OF PYRROLIDONE CARBOXYLIC ACID AND/OR SALTS THEREOF AND HYALURONIC ACID AND/OR SALTS THEREOF, FOR USE IN THE TREATMENT AND/OR PREVENTION OF DRYNESS AND IRRITATION OF THE MUCOSAE, AND RELATED PHARMACEUTICAL FORMULATIONS | 2018-12-06 |
20180344697 | VETERINARY FORMULATIONS | 2018-12-06 |
20180344698 | PROCESSES USEFUL FOR THE PREPARATION OF 1-[3-(4-BROMO-2-METHYL-2H-PYRAZOL-3-YL)-4-METHOXY-PHENYL]-3-(2,4-DIFLUORO- -PHENYL)-UREA AND CRYSTALLINE FORMS RELATED THERETO | 2018-12-06 |
20180344699 | ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER | 2018-12-06 |
20180344700 | VASOPRESSIN-LIKE ACTION ENHANCER | 2018-12-06 |
20180344701 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | 2018-12-06 |
20180344702 | METHODS FOR TREATING PATIENTS WITH HEMATOLOGIC MALIGNANCIES | 2018-12-06 |
20180344703 | Combination Therapy with Nitrated Lipids and Inhibitors of the Renin-Angiotensin-Aldosterone System | 2018-12-06 |
20180344704 | Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban | 2018-12-06 |
20180344705 | METHOD FOR TREATING CHRONIC INFLAMMATORY DISEASES | 2018-12-06 |
20180344706 | Compositions Comprising Metformin and A Glucokinase Activator | 2018-12-06 |
20180344707 | TARGETED APPROACH IN THE MANAGEMENT OF EPIDERMOLYSIS BULLOSA | 2018-12-06 |
20180344708 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | 2018-12-06 |
20180344709 | USE OF GABOXADOL IN THE TREATMENT OF TINNITUS | 2018-12-06 |
20180344710 | DRUG DELIVERY SYSTEM | 2018-12-06 |
20180344711 | COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | 2018-12-06 |
20180344712 | Methods Of Treating Fabry Patients Having Renal Impairment | 2018-12-06 |
20180344713 | METHODS FOR TREATMENT OF FIBROTIC DISEASES | 2018-12-06 |
20180344714 | TOPICAL NIFEDIPINE FORMULATIONS AND USES THEREOF | 2018-12-06 |
20180344715 | WNT/BETA-CATENIN SIGNAL TRANSDUCTION INHIBITORS AND THEIR USE IN TREATMENT OR PREVENTION OF DISEASES AND CONDITIONS LINKED WITH SAID TRANSDUCTION | 2018-12-06 |
20180344716 | NOVEL OXAZOLIDINONE DERIVATIVES | 2018-12-06 |
20180344717 | COMPOSITIONS OF TOLPERISONE | 2018-12-06 |
20180344718 | METHOD OF TREATING HYPERTENSION | 2018-12-06 |
20180344719 | TREATMENT AND PREVENTION OF OCULAR NEURODEGENERATIVE DISORDER | 2018-12-06 |
20180344720 | PRESERVATIVE-FREE PROCHLORPERAZINE NASAL SPRAY FOR MIGRAINE THERAPY | 2018-12-06 |
20180344721 | Medicinal Treatment of Chronic Inflammatory Dermal Disorders | 2018-12-06 |
20180344723 | RHO KINASE INHIBITORS | 2018-12-06 |
20180344724 | Combination Therapy | 2018-12-06 |
20180344725 | QUINOLONE CHALCONE COMPOUNDS AND USES THEREOF | 2018-12-06 |
20180344727 | COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY | 2018-12-06 |
20180344728 | PHARMACEUTICAL COMPOSITIONS | 2018-12-06 |
20180344729 | TRIAZOLE DAGLAlpha INHIBITORS | 2018-12-06 |
20180344730 | MEDICAMENT FOR TREATING MENTAL AND BEHAVIOURAL DISORDERS | 2018-12-06 |
20180344731 | METHOD OF TREATING BIPOLAR I AND II DISORDERS | 2018-12-06 |
20180344732 | METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS | 2018-12-06 |
20180344733 | 4,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF | 2018-12-06 |
20180344734 | INHIBITORS OF BETA-SECRETASE | 2018-12-06 |
20180344735 | USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION | 2018-12-06 |
20180344736 | METHODS AND MATERIALS FOR TREATING CANCER | 2018-12-06 |
20180344737 | SCREENING METHOD | 2018-12-06 |
20180344738 | 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors | 2018-12-06 |
20180344739 | (AZA)PYRIDOPYRAZOLOPYRIMIDINONES AND INDAZOLOPYRIMIDINONES AND THEIR USE | 2018-12-06 |
20180344740 | TREATMENT OF B-CELL MALIGNANCIES BY A COMBINATION JAK AND PI3K INHIBITORS | 2018-12-06 |
20180344741 | ANTIDIABETIC MEDICATIONS | 2018-12-06 |
20180344742 | METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAIN | 2018-12-06 |
20180344743 | METHODS OF TREATMENT OF ANORECTAL AND GENITAL DISORDERS | 2018-12-06 |
20180344744 | METHOD OF TREATING METASTATIC CANCER IN A SUBJECT | 2018-12-06 |
20180344745 | TREATMENT OF DEVELOPMENTAL DISORDERS WITH IMIDAZOLONE DERIVATIVES | 2018-12-06 |
20180344746 | THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME | 2018-12-06 |
20180344747 | METHODS AND SYSTEMS FOR CONDITIONING OF PARTICULATE CRYSTALLINE MATERIALS | 2018-12-06 |
20180344748 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC INFLAMMATORY DISEASES | 2018-12-06 |
20180344749 | CONTROLLED RELEASE FORMULATIONS OF SALICLATE-RELEASING ACTIVES | 2018-12-06 |
20180344750 | COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME | 2018-12-06 |
20180344751 | Broad Spectrum Antiviral and Methods of Use | 2018-12-06 |
20180344752 | THYROID HORMONE RECEPTOR AGONIST AND USE THEREOF | 2018-12-06 |
20180344753 | AMINOPHOSPHINIC DERIVATIVES FOR PREVENTING AND TREATING EYE PAIN | 2018-12-06 |
20180344754 | COMPOSITIONS FOR MANAGEMENT OF HELICOBACTER PYLORI INFECTIONS | 2018-12-06 |
20180344755 | Composition for Treating Neuropathy, Process and Method of Treatment Thereof | 2018-12-06 |
20180344756 | METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS | 2018-12-06 |
20180344757 | USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA | 2018-12-06 |
20180344758 | Method of Treating Cancer with cGAMP or cGAsMP | 2018-12-06 |
20180344759 | AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION | 2018-12-06 |
20180344760 | Use of Antisense Oligonucleotides for Producing Truncated Ig by Exon Skipping for the Treatment of Diseases Involving B Cells | 2018-12-06 |
20180344761 | Compositions and Methods for Inducing Beige or Brown Fat Tissue | 2018-12-06 |
20180344762 | INJECTABLE COMPOSITIONS AND METHODS OF USE THEREOF | 2018-12-06 |
20180344763 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | 2018-12-06 |
20180344764 | USE OF MICRORNA-146A AND NANOCERIA CONJUGATE TO IMPROVE WOUND HEALING AND PROMOTE TISSUE REGENERATION | 2018-12-06 |
20180344765 | METHOD FOR PRODUCING AN OSTEOINDUCTIVE CALCIUM PHOSPHATE AND PRODUCTS THUS OBTAINED | 2018-12-06 |
20180344766 | COMBINED ORGAN AND HEMATOPOIETIC CELLS FOR TRANSPLANTATION TOLERANCE OF GRAFTS | 2018-12-06 |
20180344767 | DIAGNOSTIC METHODS FOR T CELL THERAPY | 2018-12-06 |
20180344768 | NK CELL-BASED THERAPY | 2018-12-06 |
20180344769 | COMPOSITIONS AND METHODS FOR TREATING PERITONEAL CANCERS | 2018-12-06 |
20180344770 | Functionalized Erythroid Cells | 2018-12-06 |
20180344771 | PHARMACEUTICAL COMPOSITION COMPRISING ERYTHROCYTES ENCAPSULATING A PLP-DEPENDENT ENZYME AND ITS COFACTOR | 2018-12-06 |
20180344772 | USE OF WHEY PROTEIN MICELLES AND POLYSACCHARIDES FOR IMPROVING INSULIN PROFILE | 2018-12-06 |
20180344773 | Camel Milk Based Pharmaceutical Composition | 2018-12-06 |
20180344774 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING, AS ACTIVE INGREDIENT, STEM CELLS OVEREXPRESSING SOD3 | 2018-12-06 |
20180344775 | THERAPEUTIC AGENT FOR LIVER DISEASE CONTAINING STROMAL CELLS DERIVED FROM ADIPOSE TISSUE AND METHOD FOR PRODUCING THE SAME | 2018-12-06 |
20180344776 | Direct Reprogramming of Cells to Cardiac Myocyte Fate | 2018-12-06 |
20180344777 | METHOD OF MODULATING MULLER GLIA CELLS | 2018-12-06 |
20180344778 | Methods of Enhancing Female Fertility | 2018-12-06 |
20180344779 | COMPOSITION HAVING HYDROLYZED COLLAGEN AND MANUKA HONEY | 2018-12-06 |
20180344780 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2018-12-06 |
20180344781 | HAIR CARE COMPOSITIONS CONTAINING EXTRACELLULAR METABOLITE PREPARATION FROM BACILLUS COAGULANS | 2018-12-06 |
20180344782 | PROBIOTIC RECOLONISATION THERAPY | 2018-12-06 |
20180344783 | NATURAL INTRA-VAGINAL INSERTS TO CONTROL IMBALANCED PH | 2018-12-06 |
20180344784 | USE OF A POLYSACCHARIDE MIXTURE FOR TREATING HYPERGLYCEMIA | 2018-12-06 |
20180344785 | Methods for Extraction and Isolation of Isoprenoid and Terpene Compounds from Biological Extracts | 2018-12-06 |
20180344786 | SYSTEM AND METHOD ENHANCED CANNABINIOD EFFECT DELIVERY | 2018-12-06 |
20180344787 | METHOD FOR OBTAINING SAPONINS FROM PLANTS | 2018-12-06 |